WATSON 415 (Estropipate 1.5 mg)
Pill with imprint WATSON 415 is Orange, Round and has been identified as Estropipate 1.5 mg. It is supplied by Watson Pharmaceuticals.
Estropipate is used in the treatment of atrophic vaginitis; atrophic urethritis; hypoestrogenism; oophorectomy; osteoporosis (and more), and belongs to the drug class estrogens. Not for use in pregnancy. Estropipate 1.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for WATSON 415
Estropipate
- Imprint:
- WATSON 415
- Strength:
- 1.5 mg
- Color:
- Orange
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Estrogens
- Pregnancy Category:
- X - Not for use in pregnancy
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 52544-0415
More about estropipate
- Estropipate Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 3 Reviews
- Drug class: estrogens
Consumer resources
Other brands: Ogen 0.625, Ogen 2.5, Ogen 1.25, Ortho-Est
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
